EosDx Inc. is committed to bringing live changing innovation to breast cancer diagnostics with our fundamentally new approach. Our efforts are focused on significantly improving diagnostic procedures, which follow after a suspicious mammography image is identified. 
Ultimately our goal is to introduce completely non-invasive biopsy procedure, eliminating the need for tissue extraction. 
EosDx method uses X-ray radiation to obtain digital quantified molecular structure data of the tissue which has been shown to be highly sensitive to its health status. Research has shown that molecular structure changes immediately in response to its pathological status and this change propagates to a significant distance from the origination site, making it possible to detect pathology very early and with the highest degree of accuracy.

Biotechnology

Health Care

Health Diagnostics

EosDx Inc.

John Pavlidis

Anna Kryzhanovskaya

This department focuses on conducting and supporting clinical trials to evaluate the safety and effectiveness of new medications and treatments.

Clinical Research

This department provides strategic direction and overall leadership for the organization.

Executive Leadership

This department oversees organizational governance and ensures compliance with regulatory standards.

Governance and Oversight

This department provides expert guidance on medical practices and technologies to enhance healthcare outcomes.

EosDx Inc.

Org chart

Teams

Clinical Research

Executive Leadership

Governance and Oversight

Medical Advisory

Offices

EosDx Inc.

Org chart

Teams

Clinical Research

Executive Leadership

Governance and Oversight

Medical Advisory

Offices

Related companies